BACKGROUND: At the time of kidney transplantation (KT), almost all @entity1 have @entity417 caused by low levels of endogenous @entity1307 ( @entity1307 ), along with several other factors. After KT, @entity417 improves because of secretion of @entity1307 from the allograft. But some recipients have persistent @entity417 . Whether or not erythropoiesis-stimulating agent (ESA) hypo-responsiveness before KT affects @entity8 ( @entity8 ) remains unknown. METHODS: Sixty-eight @entity1 received KT between January 2007 and July 2012 through the Department of Urology at Kobe University Hospital, and 35 of these @entity1 were enrolled. Exclusion criteria included age  <18 years, unknown ESA dosage at transplantation, ESA start within 1 year after transplantation, and other criteria. We evaluated post-transplant hemoglobin (Hb) levels from the pre-transplant ESA responsive index (ERI): pre-transplant ESA dosage/Hb  * body weight at 1 year after transplantation. RESULTS: The mean (  SD) Hb of all @entity1 rose from 11.3    1.0  mg/dL to 12.7    1.4  mg/dL at 1 year after transplantation (P  < .01). The pre-transplant low ERI group (<10) showed significantly higher hemoglobin levels compared with the pre-transplant high ERI group (>= 10; 12.9    1.14  mg/dL versus 11.8    1.76  mg/dL, respectively; P  = .03). CONCLUSIONS: ESA hypo-responsiveness before KT carried over after KT. Low pre-transplant ERI might be a sentinel marker for @entity8 .

Pre-Transplant Erythropoiesis-Stimulating Agent Hypo-Responsiveness and XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity1307 :: ('2056', 'Gene') :: ['erythropoietin', 'EPO'] @entity8 :: ('MESH:D007674', 'Disease') :: ['PTA', 'post-transplant anemia'] @entity417 :: ('MESH:D000740', 'Disease') :: ['anemia']
@entity8 :: (MESH:D007674,Disease) :: ['Post-Transplant Anemia']
